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The subjective benefit of middle ear implantation was studied in a group of 23
hearing-impaired patients who could not use conventional hearing aids owing
to severe chronic external otitis. Changes in hearing disability (Abbreviated Profile
of Hearing Aid Benefit [APHAB]) and changes in quality of life (Glasgow
Benefit Inventory [GBI]) were determined. Mean benefit value on the APHAB
for the subscale Ease of Communication was close to the mean reference value
for conventional hearing aids. For the subscales Reverberation and Background
Noise, a poorer result was found. Individual analysis of the APHAB scores
showed significant benefit in 12 out of the 23 patients. According to the GBI,
16 out of 17 patients reported that middle ear implantation had made a positive
impact on their quality of life. It is concluded that middle ear implantation has
a positive effect on hearing difficulties and quality of life in hearing-impaired
subjects who cannot use conventional devices. The APHAB outcomes were
not better than those reported for conventional devices. 
Key Words: APHAB, Glasgow Benefit Inventory, Otologics MET, self-
assessment scales, Vibrant Soundbridge
Abbreviations: APHAB = Abbreviated Profile of Hearing Aid Benefit; AV =
Aversiveness of sounds (subscale APHAB); BN = Background Noise (subscale
APHAB); EC = Ease of Communication (subscale APHAB); GBI = Glasgow
Benefit Inventory; PHAB = Profile of Hearing Aid Benefit; RV = Reverberation
(subscale APHAB) 
Sumario 
Se estudió el beneficio subjetivo de la implantación del oído medio en un grupo
de 23 pacientes hipoacúsicos que no podían utilizar auxiliares auditivos
convencionales debido a una otitis externa crónica severa. Se determinaron
los cambios en discapacidad auditiva (Perfil Abreviado del Beneficio del
Auxiliar Auditivo [APHAB]) y los cambios en la calidad de vida (Inventario
Glasgow de Beneficio [GBI]). El valor medio de beneficio en el APHAB para
la sub-escala Facilidad de Comunicación fue cercano al valor medio de
referencia para los auxiliares auditivos convencionales. Para las sub-escalas
de Reverberación y Ruido de Fondo, se encontró un resultado más pobre. El
análisis individual de los puntajes APHAB mostró un beneficio significativo en
12 de los 23 pacientes. De acuerdo con el GBI, 16 de los 17 pacientes
reportaron que la implantación del oído medio había tenido un impacto positivo
en la calidad de sus vidas. Se concluye que la implantación del oído medio
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Over the past decade, middle earimplants have been used as analternative treatment for patients
with moderate to severe sensorineural
hearing loss. At present, two different types
of middle ear implant are commercially
available, the Vibrant Soundbridge (Ball et
al, 1997; Snik and Cremers, 2001; Luetje et
al, 2002; Sterkers et al, 2003) and the
Otologics MET device (Kasic and
Fredrickson 2001; Jenkins et al, 2004). To
describe and evaluate the effect of middle
ear implantation, frequent use is made of
audiometric variables, such as soundfield
thresholds and speech-recognition scores.
Self-assessment scales can also be used to
gain more insight into the subjective effect
of implantation. The most commonly used
questionnaire for this purpose is the stan-
dardized Abbreviated Profile of Hearing Aid
Benefit (APHAB). Developed from the
Profile of Hearing Aid Performance (PHAP)
combined with the Profile of Hearing Aid
Benefit (PHAB), the APHAB quantifies per-
sonal hearing difficulties in various every-
day listening situations (Cox and
Alexander, 1995). This questionnaire
assesses primarily hearing disability not
hearing handicap. The questionnaire com-
prises four subscales, three of which
address speech understanding in different
situations, while the fourth subscale
inquires about negative reactions to envi-
ronmental sounds. Cox et al (1991) and Cox
and Rivera (1992) reported that the original
standardized PHAB had good test-retest
reliability and sensitivity. Administration of
the APHAB before and after hearing aid fit-
ting proved to be a valuable and sensitive
method to detect the benefit of the interven-
tion (Almeida and Taguchi, 2004). 
The (A)PHAB has been used as a subjec-
tive assessment scale in several studies on
middle ear implantation (Fraysse et al,
2001; Lenarz et al, 2001; Luetje et al, 2002;
Todt et al, 2002; Uziel et al, 2003; Jenkins
et al, 2004). Comparisons were made
between APHAB scores obtained before
implantation, while the patient was still
using his conventional hearing aids, and
those obtained after implantation. In gen-
eral, positive and significant changes have
been reported, which indicates that
implanted patients experience improve-
ments compared to their conventional hear-
ing aid. However, it should be noted that, at
some stage, these patients chose an inva-
sive treatment and might feel committed;
this might bias the outcomes.
Cox and Alexander (1995) reported refer-
ence APHAB scores, obtained in a group of
patients with moderate to severe hearing
loss. These reference values will be used for
comparisons although they are based on
research in patients fitted with convention-
al linear hearing aids. 
In addition, the Glasgow Benefit
Inventory (GBI) was used. The GBI assess-
es changes in quality of life after otological
treatment (Robinson et al, 1996). Whereas
the APHAB concentrates on hearing dis-
abilities, the GBI focuses on general feel-
ings of well-being such as self-confidence,
self-esteem, happiness, and physical
health. Such target areas are important to
gain broad insight into the subjective
effects of the otological treatment. While
APHAB has been used frequently in studies
on the effect of middle ear implantation, the
GBI has only been used in one study on the
Vibrant Soundbridge (Sterkers et al, 2003).
Audiometric results of the middle ear
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tiene un efecto positivo sobre las dificultades de comunicación y sobre la calidad
de vida en sujetos hipoacúsicos que no pueden utilizar dispositivos
convencionales. Los resultados del APHAB no fueron mejores que aquellos
reportados con dispositivos convencionales. 
Palabras Clave: APHAB, Inventario Glasgow de Beneficio, Otologics MET,
escalas de auto-evaluación, Vibrant Soundbridge
Abreviaturas: APHAB = Perfil Abreviado de Beneficio del Auxiliar Auditivo;
AV = Aversión al sonido (sub-escala APHAB); BN = ruido de fondo (sub-
escala APHAB); EC = facilidad de comunicación (sub-escala APHAB); GBI =
Inventario Glasgow de Beneficio; PHAB = Perfil de Beneficio del Auxiliar
Auditivo; RV = reverberación (sub-escala APHAB)
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implant recipients at the University
Medical Centre St Radboud in Nijmegen
have been published previously (Snik and
Cremers 2001; Snik et al, 2001; Snik et al,
2004), but there was no mention of subjec-
tive self-assessments. The aim of the pres-
ent study was to evaluate the subjective
effect of middle ear implantation with the
APHAB and GBI questionnaires in a
unique study group; our group only com-
prised hearing-impaired patients with
chronic external otitis who were therefore
unable to wear conventional hearing aids
successfully. In contrast, the patients
included in the cited studies (Fraysse et al,
2001; Lenarz et al, 2001; Luetje et al, 2002;
Todt et al, 2002; Jenkins et al, 2004) included
mainly dissatisfied conventional hearing
aid users. 
The study was not aimed at a comparison
between the two middle ear implant sys-
tems because of selection bias, as the
Otologics MET device is more powerful than
the Vibrant Soundbridge (Snik et al, 2004),
but on the other hand, the Vibrant
Soundbridge is easier to implant. Therefore,
the Otologics MET was only applied in
patients with more severe hearing loss. 
MATERIALS AND METHODS
Study Design
This clinical study had a prospective sin-
gle subject (repeated) measures design, in
which each patient served as his or her
own control subject. Early in the selection
phase, all the patients filled out the
APHAB questionnaire (baseline measure-
ment). The APHAB questionnaire was
readministered to the patients six and
twelve months after audioprocessor fitting,
while the GBI questionnaire was only filled
out once, after twelve months of middle ear
implant use. In addition to the longitudinal
evaluation, the APHAB scores obtained
after implantation were compared to pub-
lished reference scores, obtained in a large
group of patients using conventional hear-
ing aids (Cox and Alexander, 1995).
To assess whether audioprocessor fitting
was adequate, realizing that these devices
make use of nonlinear amplification,
speech gain was measured and compared
to target gain values obtained with the
well-validated NAL rule (Dillon, 2001).
Speech gain was defined as the shift
between the unaided and aided speech
audiograms (speech recognition-intensity
graphs) at 65 dB input, as introduced pre-
viously (Snik and Cremers, 2001). Mean
NAL target gain values at frequencies of
0.5, 1, and 2 kHz for an input level of 65 dB
were used to compare with measured gain. 
Study Population 
The study population comprised 23
patients, 11 men and 12 women, aged 53.0
±14.5 yr (range 18–79 yr) at the time of
implantation. All the patients had symmet-
rical sensorineural hearing loss and chron-
ic, therapy-resistant external otitis.
Fourteen patients received the Vibrant
Soundbridge (with the 404 audioprocessor;
Med-El, Innsbruck, Austria), and nine
patients received the Otologics MET (with
the standard button processor; LLC,
Boulder, CO) according to the severity of
their hearing loss. The mean hearing loss
for the Vibrant Soundbridge users was 49
±8 dB HL (range 32–57 dB HL) and for the
Otologics MET users was 64 ±11 dB HL
(range 50–77 dB HL). Six weeks after
implant surgery, the audioprocessor was
fitted in a nonlinear amplification mode
according to the wishes of the patient. If
necessary, adjustments were made during
follow-up visits.
Before implantation, all the patients used
conventional hearing aids. Special ear
moulds had been applied, vented if possible
and made of allergy-free material or silver
coated. A total of 13 patients had decided to
stop using their conventional hearing aid at
some stage due to deterioration of their
chronic otitis. The others used their hearing
aids daily as long as they could stand them. 
Data on one more patient were excluded,
because he had hereditary diabetes that led
to sudden symmetrical hearing deteriora-
tion a few months after implantation, and
his final hearing thresholds were poorer




The APHAB is a standardized prospective
questionnaire that quantifies personal
Journal of the American Academy of Audiology/Volume 18, Number 6, 2007
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hearing difficulties in various everyday lis-
tening situations (Cox and Alexander, 1995)
with subscales Ease of Communication
(EC), Reverberation (RV), and Background
Noise (BN). Aversiveness of sounds (AV),
the fourth subscale, measures negative
reactions to environmental sounds. The
results of each subscale are given as per-
centages of difficulty with listening in that
specific situation. Cox and Alexander
(1995) reported aided and unaided refer-
ence scores, obtained in a group of 128
patients with moderate to severe hearing
loss, fitted with conventional linear hearing
aids. These scores will be referred to as the
“APHAB reference data” and used in the
present study for comparisons. It should be
noted that a minority of the patients stud-
ied by Cox and Alexander were fitted bin-
aurally (viz. 42%).
GBI Questionnaire
The GBI is a retrospective standardized
questionnaire that examines the impact of
an otological treatment such as middle ear
implantation on the health status of the
patient. “Health status” is defined as the
general perception of well-being, including
total psychological (general), social, and
physical well-being (Robinson et al, 1996).
Scores range from -100 to +100, which cor-
responds with profound deterioration to
great improvement in quality of life. 
Analysis
Analyses were performed on the latest
data available, that is, either twelve
months (n = 14) or six months (n = 9) after
implantation. APHAB data were available
from all 23 patients, while GBI data were
available from 17 patients. Six patients did
not fill in the 12-month questionnaires (nei-
ther the APHAB nor the GBI): two of them
because of severe illness not related to the
implantation, one other patient because of
a device failure, and the three others for
unknown reasons. Furthermore, three
patients returned only the GBI question-
naire.
Differences in scores between baseline
and middle ear implantation were analyzed
using paired T-tests and Wilcoxon tests for
normally distributed variables and not-
normally distributed variables, respective-
ly. Data are expressed as mean values ±
standard deviations. Differences between
baseline and middle ear implantation are
expressed as mean with their 95% confi-
dence interval. If p < 0.05 then the differ-
ences are considered statistically signifi-
cant. Analysis of variance was used to
investigate the possible influence of the
type of middle ear implant. SPSS 12.0 sta-
tistical software was used for all calcula-
tions.
Individual differences in APHAB scores
were checked for significance using the
guidelines formulated by Cox and
Alexander (1995). The 95% critical differ-
ence on the APHAB subscales EC, RV, and
BN was 26%. The 95% critical difference on
the subscale AV was 21% when no conven-
tional hearing aid had been used at base-
line, versus 36% when a hearing aid had
been used. In the joint evaluation of the
APHAB subscales EC, RV, and BN, a differ-
ence of 10% or more for each subscale was
considered to be significant (p < 0.02). 
RESULTS
Fitting Audioprocessors
The average difference between the
measured gain and target gain calculated
with the NAL rule was 2.3 ± 6.4 dB (range
-11.5 to 7.6 dB). This indicated that on the
average the audioprocessor fitting was ade-
quate. The mean aided phoneme score at a
presentation level of 65 dB SPL was 83%
±13% (range: 55% to 95%). Five of the
patients continued to use their convention-
al device in the contralateral ear, especially
during demanding listening situations. 
Self-Assessment Scales
APHAB Questionnaire
Figure 1 presents the mean APHAB
scores and SD as obtained before implanta-
tion and at 6 and 12 months after fitting of
the device. Only the scores from the 14
patients with a complete set of question-
naire data were used. The figure shows
that there is an obvious improvement in the
EC, BN, and RV scores after device fitting
and that these changes are rather stable
Subjective Effect of Middle Ear Implantation/Snik et al
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over time. It was decided that the 12-month
data would be used for further statistical
analysis supplemented with the 6-month
data for the remaining nine patients.
Table 1 shows the results of the four
APHAB subscales at baseline and after
middle ear implantation. Scores on the sub-
scales EC, RV, and BN were significantly
lower after middle ear implantation than at
baseline (p < 0.001, p = 0.02 and 0.03,
respectively), whereas AV scores were high-
er after middle ear implantation than at
baseline, but this difference was not signif-
icant (p = 0.62). 
Results of the individual analysis accord-
ing to the guidelines formulated by Cox and
Alexander (1995) are given in Table 2. This
table shows that in several patients there
was significant improvement in APHAB
scores between baseline and middle ear
implantation. The number of patients with
a significant deterioration is also listed.
Altogether, in 12 out of the 23 patients
(52%) a significant improvement was found
on one of the APHAB subscales or on the
combined subscales. Figure 2 shows the
mean scores on the APHAB subscales in the
present study compared with the reference
values reported by Cox and Alexander
(1995). 
Benefit scores (difference between base-
line and postintervention values) on the
four subscales were comparable between
the patients with the Vibrant Soundbridge
and those with the Otologics MET; statisti-
cally significant differences were not pres-
ent (p = 0.86 to 1.00). 
Journal of the American Academy of Audiology/Volume 18, Number 6, 2007
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Figure 1. Mean APHAB scores per category, obtained before implantation (first bars) and 6 months (mid-
dle bars) and 12 months (last bars) follow-up, for the subgroup of 14 patients with a complete data set. Stan-
dard deviations are indicated.
Table 1. Average APHAB Scores (%)
APHAB subscale Baseline MEI MEI; baseline p-value*
Mean ± SD Mean ± SD Mean (95% CI)
Ease of Communication 48.8 ± 20.8 29.2 ± 17.3 19.6 (9.0–30.1) <0.001
Reverberation 67.9 ± 21.3 55.2 ± 18.7 12.7 (2.6–22.9) 0.02
Background Noise 65.8 ± 18.6 56.5 ± 11.6 9.2 (1.3–17.2) 0.03
Aversiveness 37.1 ± 25.1 39.6 ± 24.6 -2.5 (-12.7–7.7) 0.62
Note: n = 23.  
*p < 0.05 was considered statistically significant 
Table 2. Number of Patients with Significant Differences in APHAB Scores 
APHAB subscale # significant benefit # significant deterioration 
implantation-baseline implantation-baseline
Ease of Communication 10 0
Reverberation 9 1
Background Noise 6 0
Aversiveness 1 1
Subscales jointly (EC, RV, and BN) 8 1
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GBI Questionnaire
Table 3 shows the GBI results on the three
subscales and the overall score, 12 months
after middle ear implantation. Scores on the
GBI were comparable for patients with the
Vibrant Soundbridge and those with the
Otologics MET (p = 0.19 to 0.51). 
DISCUSSION 
The present prospective study on hear-ing-impaired patients with severe
external otitis addressed the subjective
effect of middle ear implantation on hear-
ing difficulties and quality of life. To obtain
data, we used the APHAB and GBI ques-
tionnaires. First of all, it was studied
whether or not the amplification (gain) of
the middle ear implants was adequate. On
the average, the difference between meas-
ured gain and the NAL target gain was neg-
ligible; however, there was spread in the
data. To obtain additional evidence con-
cerning the appropriateness of the fittings,
Pearson correlation coefficients were calcu-
lated between the individual differences
between NAL target gain and measured
gain on the one hand and individual
APHAB benefit scores on the other.
Nonsignificant correlations were found
(Pearson’s rho between 0.02 and -0.11).
Therefore, it is concluded that the quality of
device fitting in terms of gain was ade-
quate.
APHAB Scores 
Table 1 and Figure 2 show that, as
expected, our patients experienced signifi-
cantly fewer problems in the domains EC,
RV, and BN of the APHAB after implanta-
tion than at baseline. In contrast the sub-
scale AV showed small but nonsignificant
deterioration. Figure 2 also shows that the
APHAB scores of our patients after implan-
tation are less favorable than the aided
APHAB reference data, except for EC. 
In comparison with other studies on mid-
dle ear implants (Fraysse et al, 2001;
Lenarz et al, 2001; Luetje et al, 2002; Todt
et al, 2002; Uziel et al, 2003; Jenkins et al,
2004), our postimplantation scores are
poorer. Typically, mean literature scores are
in between the present scores and the aided
APHAB reference scores. At least two fac-
tors might have played a role. All our sub-
jects had external otitis and were therefore
unable to wear conventional hearing aids
successfully. Thus, middle ear implantation
had been performed on a medical indica-
tion. In all the other studies, at least a pro-
portion of the population had received a
middle ear implant on nonmedical grounds.
Examples of these reasons were physical
discomfort, dissatisfaction with sound qual-
ity, and acoustic feedback (Fraysse et al,
2001; Lenarz et al, 2001; Luetje et al, 2002;
Todt et al, 2002; Jenkins et al, 2004) as well
as cosmetic complaints (Uziel et al, 2003).
Subjective Effect of Middle Ear Implantation/Snik et al
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Figure 2. Mean APHAB scores obtained before implanta-
tion (“pre-impl”) and after implantation (“post-impl”). For ref-
erence purposes, unaided and aided mean scores are added
as reported by Cox and Alexander (1995; “Cox unaided,” “Cox
aided”). EC = Ease of Communication, RV = (speech recog-
nition in) Reverberation; BN = (speech recognition in) Back-
ground Noise, AV = Aversiveness (of sounds).
Table 3. Average GBI Scores
GBI subscale p-value* Benefit score Impact (%)
Mean ± SD Positive No change Negative
Average (overall) <0.001 32.9 ± 15.4 94.1 5.9 0.0
General <0.001 41.5 ± 15.2 100.0 0.0 0.0
Social 0.008 17.6 ± 23.9 47.1 52.9 0.0
Physical 0.10 15.7 ± 37.5 35.3 41.2 23.5
Note: n = 17.   
* p < 0.05 was considered statistically significant
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It is conceivable that the subjective results
of patients who dislike their conventional
device are biased, which might explain the
better APHAB scores reported in literature.
Another variable that affects the reliability
of questionnaire scores is the timing of the
postoperative measurements. If the
patients are evaluated too soon they will
lack experience with the implant, and
enthusiasm bias might be present owing to
feelings of gratitude. We had a relatively
long follow-up period, (substantially) longer
than in the other studies. In summary, it is
suggested that the present data are proba-
bly the most appropriate ones owing to less
bias than generally found in the middle ear
implant literature. 
The poorer BN and RV scores that we
found postimplantation might be ascribed
to the unilateral application of the middle
ear implant; 42% of the Cox and Alexander
reference group (1995) used bilateral
devices while in our study population this
figure was 22% (five of our patients contin-
ued to use their conventional device in the
contralateral ear; two of them permanently,
the other three incidentally). Figure 3
shows our mean result as well as the indi-
vidual result of the two patients who used a
conventional device permanently in the
contralateral ear. Little difference is seen.
Lenarz et al (2001) also studied postim-
plantation APHAB scores. Twelve of their
patients (35%) consistently used a conven-
tional hearing aid in their nonimplanted
ear; the mean data of Lenarz et al are also
plotted in Figure 3. This proportion of 35%
is close to the 42% of binaural hearing aid
users in the APHAB reference group. At
last, the 20th, 35th, and 50th percentile
scores taken from that reference group are
plotted (Cox and Alexander, 1995). As all
the scores presented in Figure 3 are clearly
below p50, it is suggested that the differ-
ences in APHAB scores between middle ear
implant users and the APHAB norms can-
not solely be ascribed to unilateral versus
bilateral fittings. Therefore, probably,
sound quality of the middle ear implants
plays a part.
Analysis of the individual APHAB bene-
fit scores according to the guidelines formu-
lated by Cox and Alexander (1995) revealed
significant benefit on the subscales EC and
RV in about 40% of our patients and 25%
for BN (see Table 2). When the subscales
were analyzed jointly, 35% of the patients
had fewer problems in communication than
at baseline, versus 4% (one patient) who
showed significant deterioration in commu-
nication. Altogether 52% of our patients
showed a significant improvement on one
specific subscale or on the three subscales
EC, RV, and BN combined. Such individual
analyses were not performed in the previ-
ous studies, except by Fraysse et al (2001).
They reported a significant benefit in 70%
of their patients. 
GBI Results 
Table 3 presents the GBI scores. In the
GBI, the social and physical subscales con-
tain just three questions each; therefore,
the discussion is focused on the overall
score. In the literature, only Sterkers et al
(2003) used the GBI to assess the change in
quality of life after middle ear implanta-
tion. An overall GBI profit score of 17 was
reported in their multicenter study, com-
pared to our overall profit value of 33. The
fact that our patients had trouble wearing
any conventional hearing aids might
explain our relatively high mean GBI score.
After all, after implantation our patients
could hear well without pain and/or itching
and therefore probably felt more comfort-
able in life. 
Journal of the American Academy of Audiology/Volume 18, Number 6, 2007
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Figure 3. Mean postintervention APHAB scores for the
whole group (mean) and individual data from the two patients
who used a conventional device in their contralateral ear (“pat
1” “pat 2”). Furthermore, the mean scores reported by Lenarz
et al (2001) are added and, for reference purposes, the 20th
(p20), 35th (p35), and 50th (p50) percentile scores as reported
by Cox and Alexander (1995). EC = Ease of Communication,
RV = (speech recognition in) Reverberation; BN = (speech
recognition in) Background Noise. 
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Six of our patients did not fill out the
GBI. A comparison was made between the
APHAB scores of these 6 patients compared
to that of the rest of the group. No signifi-
cant difference was found that suggests
that the 17 subjects formed a representa-
tive subgroup. 
The change in quality of life after middle
ear implantation measured with the GBI
was comparable to that after BAHA treat-
ment (a semi-implantable bone-conduction
device); GBI scores of 31 (Arunchalam et al,
2001) and 33 (McLarnon et al, 2004) were
reported. Somewhat higher GBI scores
were reported after cochlear implantation
of 36 (Vermeire et al, 2005), 40 (Robinson et
al, 1996), and 45 (UK Cochlear Implant
Study Group, 2004).
This study demonstrated the positive
subjective effects of middle ear implantation
on hearing difficulties and quality of life in
hearing-impaired patients with severe
external otitis. Results of the APHAB indi-
cated improvements in perceived hearing
disability; however, this benefit was moder-
ate in comparison with previous studies on
middle ear implantation as well as in com-
parison with APHAB reference data. Thus,
although the surplus value of middle ear
implantation over conventional hearing
aids was not shown, middle ear implanta-
tion was highly beneficial and appreciated;
according to the GBI, our subjects, with
severe external otitis, experienced great
improvement in their quality of life. 
REFERENCES
Almeida K de, Taguchi CK. (2004) The use of the self-
assessment questionnaire to evaluate hearing aid benefit.
Pro Fono 16:101–110.
Arunachalam PS, Kilby D, Meikle D, Davison T, Johnson
IJM. (2001) Bone-anchored hearing aid quality of life
assessed by Glasgow Benefit Inventory. Laryngoscope
111:1260–1263.
Ball G, Huber A, Goode RL. (1997) Scanning laser Doppler
vibrometry of the middle ear ossicles. Ear Nose Throat
J 76:213–218.
Cox RM, Alexander GC. (1995) The abbreviated profile
of hearing aid benefit. Ear Hear 16:176–186.
Cox RM, Gilmore C, Alexander GC. (1991) Comparison
of two questionnaires for patient-assessed hearing aid
benefit. J Am Acad Audiol 2:134–145.
Cox RM, Rivera IM. (1992) Predictability and reliabil-
ity of hearing aid benefit measured using the PHAB. J
Am Acad Audiol 3:242–254.
Dillon H. (2001) Hearing Aids. New York: Thieme Verlag.
Fraysse B, Lavieille J-P, Schmerber S, Enée V, Truy E,
Vincent C, Vaneecloo FM, Sterkers O. (2001) A multi-
center study of the Vibrant Soundbridge middle ear
implant: early clinical results and experience. Otol
Neurotol 22:952–961. 
Jenkins HA, Niparko JK, Slattery WH, Neely JG,
Fredrickson JM. (2004) Otologics middle ear transducerTM
ossicular stimulator: performance results with varying
degrees of sensorineural hearing loss. Acta Otolaryngol
124:391–394.
Kasic JF, Fredrickson JM. (2001) The Otologics MET ossic-
ular stimulator. Otolaryngol Clin North Am 34:501–513.
Lenarz T, Weber BP, Issing PR, Gnadeberg D, Ambjornsen
K, Mack KF, Winter M. (2001) Vibrant Soundbridge
implant: a new hearing prosthesis for patients with sen-
sorineural hearing loss. Part 2: audiological results.
Laryngorhinootologie 80:370–380.
Luetje CM, Brackman D, Balkany TJ, Maw J, Baker
RS, Kelsall D, Backous D, Miyamoto R, Pansier S, Arts
A. (2002) Phase III clinical trial results with the Vibrant
Soundbridge implantable middle ear hearing device: a
prospective controlled multicenter study. Otolaryngol
Head Neck Surg 126:97–107.
McLarnon CM, Davison T, Johnson IJM. (2004) Bone-
anchored hearing aid: comparison of benefit by patient
subgroups. Laryngoscope 114:942–944.
Robinson K, Gatehouse S, Browning GC. (1996)
Measuring benefit from otorhinolaryngological surgery
and therapy. Ann Otol Rhinol Laryngol 105:415–422.
Snik AFM, Cremers CWRJ. (2001) Vibrant semi-
implantable hearing device with digital sound processing.
Effective gain and speech perception. Arch Otolaryngol
Head Neck Surg 127:1433–1437.
Snik AFM, Noten J, Cremers CWRJ. (2004) Gain and
maximal output of two electromagnetic middle ear
implants: are real ear measurements helpful? J Am Acad
Audiol 15:249–257.
Snik AFM, Mylanus EAM, Cremers CWRJ, Dillier N,
Fisch U, Gnadeberg D, Lenarz T, Mazolli M, Babighian
G, Uziel AS, Cooper HR, O’Connor AF, Fraysse B,
Charachon R, Shehata-Dieler WE. (2001) Multicenter
audiometric results with the Vibrant Soundbridge, a
semi-implantable hearing device for sensorineural hear-
ing impairment. Otolaryngol Clin North Am 34:373–388.
Sterkers O, Boucarra D, Labassi S, Bebear JP, Dubreuil
C, Frachet B, Fraysse B, Lavieille JP, Magnan J, Martin
C, Truy E, Uziel A, Vaneecloo FM. (2003) A middle ear
implant, the Symphonix Vibrant Soundbridge: retro-
spective study of the first 125 patients implanted in
France. Otol Neurotol 24:427–436.
Todt I, Seidl RO, Gross M, Ernst A. (2002) Comparison
of different Vibrant Soundbridge audioprocessors with
conventional hearing aids. Otol Neurotol 23:669–673.
Subjective Effect of Middle Ear Implantation/Snik et al
503
